Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death

Section of Endocrinology, Diabetes, Nutrition, Boston University, Boston, Massachusetts, United States
New England Journal of Medicine (Impact Factor: 55.87). 12/2006; 355(25):2631-9. DOI: 10.1056/NEJMoa055373
Source: PubMed


Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events.
We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio.
During follow-up (median, 7.4 years), 207 participants died and 169 had a first major cardiovascular event. In Cox proportional-hazards models adjusting for conventional risk factors, the following biomarkers most strongly predicted the risk of death (each biomarker is followed by the adjusted hazard ratio per 1 SD increment in the log values): B-type natriuretic peptide level (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine level (1.20), and renin level (1.17). The biomarkers that most strongly predicted major cardiovascular events were B-type natriuretic peptide level (adjusted hazard ratio, 1.25 per 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20). Persons with "multimarker" scores (based on regression coefficients of significant biomarkers) in the highest quintile as compared with those with scores in the lowest two quintiles had elevated risks of death (adjusted hazard ratio, 4.08; P<0.001) and major cardiovascular events (adjusted hazard ratio, 1.84; P=0.02). However, the addition of multimarker scores to conventional risk factors resulted in only small increases in the ability to classify risk, as measured by the C statistic.
For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.

Download full-text


Available from: Philimon Gona
  • Source
    • "Efforts have subsequently been made to identify new predictors of coronary artery disease (CAD)[123] as 20% of coronary events occur in the absence of traditional risk factors.[4] To determine whether there are psychological risk factors for CAD has been a challenge for evidence-based medicine, however, it is not prudent to affirm that they do not affect it pathogenesis, since depression and psychological stress have been associated with increased risk of CAD.[56789] Denollet et al. proposed that there is a type-D or “distressed” personality that describes individuals with high levels of negative affectivity (NA) and social inhibition (SI). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Type-D personality has been identified as a risk factor for general and cardiac mortality in patients with coronary artery disease (CAD). Dobutamine-atropine stress echocardiography (DASE) is an established method for non-invasive evaluation of myocardial ischemia in patients with CAD. The objective of this study was to evaluate the prevalence of type-D personality and its association with the occurrence of myocardial ischemia as assessed by DASE. Methods: This case-control study enrolled 306 patients (61 ± 9.6 years, 57.8% female) who were referred by physicians to assessment of myocardial ischemia. Before undergoing DASE, the patients answered the type-D scale, which identifies type-D personality. Results: Type-D personality was identified in 106 patients (34.6%). DASE was positive for myocardial ischemia in 32.4% (99) of 306 participants there was no significant association between type-D personality and ischemic changes on DASE (P = 0.941; odds ratio: 0.98; confidence interval 95%: 0.57-1.69). Chest pain was the only clinical variable with statistically significant prevalence in type-D personality patients (77.4% vs. 57.0%; P < 0.001). Conclusions: Type-D personality was not a significant risk factor for the presence of ischemic changes on DASE. Patients with type-D personality tended to complain more frequently of chest pain than non-type-D patients.
    Full-text · Article · Jul 2014 · International journal of preventive medicine
  • Source
    • "In very old age, cardiovascular disease is an important cause of disability, morbidity and mortality (Laslett et al. 2012; Murray et al. 2012). In recent decades, research into new risk markers for cardiovascular disease (Kavousi et al. 2012; Kistorp et al. 2005; Zethelius et al. 2008; Melander et al. 2009; Wang et al. 2006; Pikula et al. 2012) has shown that N-terminal pro-Btype natriuretic peptide (NT-proBNP) is not only a marker of heart failure but also a promising risk marker for the development of cardiovascular disease and mortality , both in primary and secondary preventions (Nadir et al. 2012; Welsh et al. 2013; Campbell 2008; Di Angelantonio et al. 2009; Olsen et al. 2007; Wannamethee et al. 2011; Marz et al. 2007) However, data in older populations are scarce (Ueda et al. 2003; Vaes et al. 2009a; Valle et al. 2005) and have sometimes been reported exclusively for secondary prevention (van Peet et al. 2013a). As traditional risk markers gradually lose their predictive value with age (Uthoff et al. 2010; de Ruijter et al. 2009; van Peet et al. 2013b), NTproBNP may become an increasingly important risk marker for cardiovascular disease and mortality in older age groups (Ueda et al. 2003; Vaes et al. 2009a, b; Valle et al. 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the aging society, it is important to identify very old persons at high risk of functional decline, cardiovascular disease and mortality. However, traditional risk markers lose their predictive value with age. We investigated whether plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels predict change in functional status, cardiovascular morbidity and mortality in very old age. Here we present an observational prospective cohort study (Leiden 85-plus Study, 1997-2004) in a population-based sample of 560 individuals aged 85 years with a 5-year complete follow-up for functional status, cardiovascular morbidity and cause-specific mortality. Median NT-proBNP for men was 351 pg/ml (cutoff values for low-medium tertiles 201 pg/ml and medium-high tertiles 649 pg/ml) and, for women, 297 pg/ml (cutoffs 204 and 519 pg/ml, respectively). During the 5-year follow-up, participants with high NT-proBNP had an accelerated cognitive decline and increase of activities of daily living (ADL) disability over time (all at p < 0.01) and an increased risk of incident heart failure [hazard ratio (HR) 3.3 (95 % confidence interval (CI) 1.8-6.1)], atrial fibrillation [HR 4.1 (2.0-8.7)], myocardial infarction [HR 2.1 (1.2-3.7)], stroke [HR 3.4 (1.9-6.3)], cardiovascular mortality [HR 5.5 (3.1-10)], non-cardiovascular mortality [HR 2.0 (1.4-3.0)] and all-cause mortality [HR 2.9 (2.1-4.0)], independent of other known risk markers. All results remained similar after exclusion of participants with heart failure at baseline. In very old age, high-NT-proBNP levels predict accelerated cognitive and functional decline, as well as cardiovascular morbidity and mortality. Results suggest that NT-proBNP can help clinicians to identify very old people at high risk of functional impairment and incident cardiovascular morbidity.
    Full-text · Article · May 2014 · Age
  • Source
    • "Regarding the association of CRP and BNP as prognostic markers, an investigation of the Framingham Offspring Study which compared C-statistic between models with traditional risk factors only and with the addition of a multi-marker score that included both hs-CRP and BNP found that only BNP led to a to a small increase in the ability of the model in discriminating between death and survival in older adults [48]. On the other hand, CRP and NT-proBNP, a precursor of BNP, were independently related to CV and overall mortality and a score formed by the two biomarkers plus three others substantially improved the predictive ability over conventional risk factors in a population of older adults with mean age of 71 years [49]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: New biomarkers may aid in preventive and end-of-life decisions in older adults if they enhance the prognostic ability of traditional risk factors. We investigated whether C-reactive protein (CRP) and/or B-type natriuretic peptide (BNP) improve the ability to predict overall mortality among the elderly of the Bambuí, Brazil Study of Aging when added to traditional risk factors. From 1997 to 2007, 1,470 community-dwelling individuals (≥60 years) were followed-up. Death was ascertained by continuous verification of death certificates. We calculated hazard ratios per 1 standard deviation change (HR) of death for traditional risk factors only (old model), and traditional risk factors plus CRP and/or BNP (new models) and assessed calibration of the models. Subsequently, we compared c-statistic of each of the new models to the old one, and calculated integrated discriminative improvement (IDI) and net reclassification improvement (NRI). 544 (37.0%) participants died in a mean follow-up time of 9.0 years. CRP (HR 1.28, 95% CI 1.17-1.40), BNP (HR 1.31 95% CI 1.19-1.45), and CRP plus BNP (HR 1.26, 95% CI 1.15-1.38, and HR 1.29, 95% CI 1.16-1.42, respectively) were independent determinants of mortality. All models were well-calibrated. Discrimination was similar among the old (c-statistic 0.78 [0.78-0.81]) and new models (p=0.43 for CRP; p=0.57 for BNP; and p=0.31 for CRP plus BNP). Compared to the old model, CRP, BNP, and CRP plus BNP models led to an IDI of 0.009 (p<0.001), -0.005 (p<0.001) and -0.003 (p=0.84), and a NRI of 0.04 (p=0.24), 0.07 (p=0.08) and 0.06 (p=0.10), respectively. Despite being independent predictors of long-term risk of death, compared to traditional risk factors CRP and/or BNP led to either a modest or non-significant improvement in the ability of predicting all-cause mortality in older adults.
    Full-text · Article · Sep 2013 · PLoS ONE
Show more